Ingevity Corporation unveils investor overview highlighting 2024 financial performance and global business segments

Reuters
2025/11/18
Ingevity Corporation unveils investor overview highlighting 2024 financial performance and global business segments

Ingevity Corporation has released an investor overview detailing its financial and operational performance for the year ended December 31, 2024. The company reported $1.2 billion in revenue, with an adjusted EBITDA margin of 31.4%. Adjusted EBITDA reached $376.5 million, while net income showed a loss of $121.4 million. Cash flow provided by operating activities totaled $128.6 million, and free cash flow was $51 million. The company operates in 75 countries, with approximately 1,500 employees and 11 manufacturing sites worldwide. Net sales were geographically diversified, with 54% from North America, 27% from Asia-Pacific, 14% from Europe, the Middle East & Africa, and 4% from South America. Ingevity's business is organized into three segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. Segment sales in 2024 were $609.6 million for Carbon Technologies, $188.6 million for Caprolactone Technologies, and $401.9 million for Road Technologies. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ingevity Corporation published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10